P. Bourguignon

发表

Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen.

V. A. Stewart, M. Demoitié, Joe D. Cohen, 2008, Vaccine.

Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity.

P. Chomez, H. Carlsen, Abdelatif Elouahabi, 2011, Vaccine.

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.

Kwaku Poku Asante, W. Hogrefe, E. Jongert, 2020, The Lancet. Infectious diseases.

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.

Kwaku Poku Asante, S. Günther, W. Hogrefe, 2020, The Lancet. Infectious diseases.

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults

T. Harrer, D. Podzamczer, C. Katlama, 2016, Medicine.

Immunogenicity and Safety of a Booster Dose of an Investigational Adjuvanted Polyprotein HIV-1 Vaccine in Healthy Adults and Effect of Administration of Chloroquine

G. Leroux-Roels, M. Janssens, Laurence Fissette, 2014, Clinical and Vaccine Immunology.

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

R. A. van den Berg, B. Lambrecht, A. Smilde, 2017 .

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants

P. van Damme, U. D'Oro, O. Finco, 2021, NPJ vaccines.

Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.

T. Harrer, J. van Lunzen, G. Fätkenheuer, 2014, Vaccine.

Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.

M. Demoitié, Joe D. Cohen, O. Ofori-Anyinam, 2013, American journal of respiratory and critical care medicine.

Vaccine-induced HIV seropositivity: a problem on the rise.

G. Leroux-Roels, M. Koutsoukos, P. Bourguignon, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients.

G. Leroux-Roels, L. Vandekerckhove, P. Moris, 2014, Journal of immunological methods.

Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques

F. Tangy, N. Dumey, C. Lorin, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.

M. Altfeld, G. Leroux-Roels, M. Janssens, 2010, Vaccine.

Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells

B. Lambrecht, B. Malissen, A. Didierlaurent, 2014, The Journal of Immunology.

Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques

F. Tangy, N. Dumey, C. Lorin, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults

G. Omosa-Manyonyi, E. Chomba, J. Mpendo, 2015, PloS one.

Induction of Strong HIV-1–Specific CD4+ T-Cell Responses Using an HIV-1 gp120/NefTat Vaccine Adjuvanted With AS02A in Antiretroviral-Treated HIV-1–Infected Individuals

M. Altfeld, M. Demoitié, T. Flynn, 2012, Journal of acquired immune deficiency syndromes.

An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers

I. Carletti, M. Demoitié, G. Leroux-Roels, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial.

Allan C. deCamp, J. Kublin, S. Buchbinder, 2016, Current opinion in virology.

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

R. A. van den Berg, B. Lambrecht, A. Smilde, 2017 .

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

R. A. van den Berg, B. Lambrecht, A. Smilde, 2017, npj Vaccines.

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.

M. Altfeld, G. Leroux-Roels, M. Janssens, 2010, Vaccine.

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

R. A. van den Berg, B. Lambrecht, A. Smilde, 2017, npj Vaccines.